Airsculpt Technologies, Inc.
AIRS Nasdaq· Services-Offices & Clinics Of Doctors Of Medicine
Last close · Oct 23, 2026
$1.20
KIRA · Stoqly’s AI analyst, in plain words
- Airsculpt Technologies, Inc. had $152M of revenue in fiscal 2025, down 15.8% on the year before. Over five years, revenue changed +19.3% a year on average.
- Its operating margin was −7.6%, down 6.7 pts: of every 100 in sales, about −8 is left after running the business.
- Airsculpt Technologies, Inc. lost $11.7M in fiscal 2025.
- Free cash flow was $0.7M in fiscal 2025, 0.5% of revenue.
- Airsculpt Technologies, Inc. returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 4.8%.
- Airsculpt Technologies, Inc. owes $47.6M more than it holds in cash, about 39.0 years of operating profit.
Market cap
$84.9M
P/E
—
Revenue
$152M
Net income
−$11.7M
Free cash flow
$0.7M
Operating margin
−7.6%
Airsculpt Technologies, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−15.8%
No. Sales fell 15.8% last year.
Does it make a profit?
−7.7%
No. It lost money last year.
Does profit turn into cash?
0.5%
Partly. 0.5% of sales ends up as free cash.
Is debt under control?
39.0x
Heavy. Repaying its debt would take 39.0 years of operating profit.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Airsculpt Technologies, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Legal name
- Airsculpt Technologies, Inc.
- CIK
- 0001870940
Airsculpt Technologies, Inc. · AIRS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $133M | $169M | $196M | $180M | $152M |
| Revenue growth | 112.4% | 26.6% | 16.1% | −7.9% | −15.8% |
| Operating margin | 11.8% | −2.7% | 5.0% | −0.9% | −7.6% |
| Net income | $10.6M | −$14.7M | −$4.2M | −$8.0M | −$11.7M |
| Net margin | 7.9% | −8.7% | −2.2% | −4.4% | −7.7% |
| Diluted EPS | −$0.01 | −$0.26 | −$0.08 | −$0.14 | −$0.19 |
| Cash | |||||
| Cash from operations | $26.6M | $24.4M | $24.0M | $11.4M | $3.1M |
| Capital expenditure | $7.1M | $12.9M | $9.9M | $14.0M | $2.4M |
| Free cash flow | $19.5M | $11.5M | $14.0M | −$2.7M | $0.7M |
| FCF margin | 14.6% | 6.8% | 7.2% | −1.5% | 0.5% |
| Dividends paid | $0.0M | $23.2M | $0.4M | $0.3M | $0.0M |
| Share count change | — | 0.1% | 2.0% | 1.6% | 4.8% |
| Debt and strength | |||||
| Cash and short-term investments | $25.3M | $9.6M | $10.3M | $8.2M | $8.4M |
| Debt incl. finance leases | $82.6M | $83.5M | $71.6M | $69.7M | $56.0M |
| Shareholders' equity | $83.5M | $70.8M | $82.7M | $78.2M | $87.7M |
| Net debt / EBITDA | 2.6x | 21.0x | 3.1x | 6.0x | 39.0x |
| Current ratio | 1.8x | 0.7x | 0.8x | 0.6x | 0.6x |
| Interest coverage | 3.2x | −0.7x | 1.5x | −0.3x | −1.9x |
| Returns and quality | |||||
| Return on capital | 10.9% | −2.5% | 4.4% | −0.9% | −6.7% |
| Return on equity | 12.6% | −19.0% | −5.5% | −10.0% | −14.1% |
| Piotroski F-score | 6 | 3 | 6 | 3 | 3 |
| Altman Z'' | 1.7 | −0.0 | 0.6 | −0.2 | −0.6 |
Insiders bought, 12 months
$2.0M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Airsculpt Technologies, Inc. · AIRS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.20 a share, the company is worth $84.9M.
Source: SEC EDGAR XBRL filings (CIK 0001870940). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.